eISSN: 1897-4252
ISSN: 1731-5530
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery
Current issue Archive About the journal Supplements Editorial board Abstracting and indexing Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank

 
2/2021
vol. 18
 
Share:
Share:
more
 
 
abstract:
Original paper

Autologous fibrin sealant application in cardiac surgery – a single-centre observational study

Radosław Jarząbek
1
,
Krzysztof Greberski
2
,
Paweł Bugajski
2

1.
Department of Cardiac Surgery, J. Struœ Municipal Hospital, Poznan, Poland
2.
Faculty of Health Sciences, University of Medical Sciences, Poznan, Poland
Kardiochirurgia i Torakochirurgia Polska 2021; 18 (2): 75-79
Online publish date: 2021/07/05
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
To minimize the risk of blood loss and post-transfusion complications in patients undergoing cardiovascular surgery, different strategies are used. Aim: To analyse the efficacy of the intraoperative use of autologous fibrin glue to seal suture lines of cardiac and vascular structures.

Material and methods
The early results of 62 patients who underwent complex cardiac operations in extracorporeal circulation were analysed. In a half of them Vivostat autologous fibrin sealant in addition to the routine haemostatic agents was applied (study group), whereas in the second group (matched-pair control group) only standard haemostatics were used. Among many other factors, special attention was paid to postoperative drainage and blood products used.

Results
The mean age of the patients and prevalence of comorbidities did not differ between groups. Generally, in the study group fewer haemostatic agents were used. For example, Preveleak tissue glue was applied in 3.2% of studied cases compared to one third of control patients (p = 0.008). The thoracic drainage on either day 0 or day 1 was also similar. The number of patients who received blood products did not differ between groups. More importantly, there were no significant differences in in-hospital mortality and prevalence of other postoperative complications.

Conclusions
In this study it was found that application of autologous fibrin glue was safe and might limit use of standard haemostatic agents. Taking into account the lack of potential threats related to the transmission of infections and immune responses, it may be an interesting alternative to the previously used local haemostatics.

keywords:

autologous fibrin sealant, Vivostat, cardiac surgery

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe